Perlmutter Cancer Center at NYU Langone GYN Oncology Associates — Mineola, New York

Perlmutter Cancer Center at NYU Langone GYN Oncology Associates is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center at NYU Langone GYN Oncology Associates has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center at NYU Langone GYN Oncology Associates?

Perlmutter Cancer Center at NYU Langone GYN Oncology Associates has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center at NYU Langone GYN Oncology Associates conducted?

Perlmutter Cancer Center at NYU Langone GYN Oncology Associates has 1 clinical trials on record, with 1 currently active. Their work covers Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms.

Is Perlmutter Cancer Center at NYU Langone GYN Oncology Associates accredited by Crixeo Health?

Perlmutter Cancer Center at NYU Langone GYN Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter Cancer Center at NYU Langone GYN Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.